Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX
· Real-Time Price · USD
3.01
0.31 (11.69%)
At close: Sep 05, 2025, 12:59 PM
11.69% (1D)
| Bid | 2.94 |
| Market Cap | 19.01M |
| Revenue (ttm) | 3.19M |
| Net Income (ttm) | -11.98M |
| EPS (ttm) | -6.5 |
| PE Ratio (ttm) | -0.46 |
| Forward PE | -2.06 |
| Analyst | Buy |
| Ask | 3.03 |
| Volume | 75,788 |
| Avg. Volume (20D) | 106,879 |
| Open | 2.71 |
| Previous Close | 2.69 |
| Day's Range | 2.71 - 3.03 |
| 52-Week Range | 1.20 - 17.75 |
| Beta | 0.14 |
About EVAX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol EVAX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for EVAX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
-5.92%
Evaxion shares are trading lower after the company...
Unlock content with
Pro Subscription
3 months ago
+25.53%
Evaxion shares are trading higher after the company reported better-than-expected Q1 GAAP EPS results.
